<DOC>
	<DOCNO>NCT00948155</DOCNO>
	<brief_summary>This study demonstrate behavioral response varenicline , help well understand mechanism . Hypotheses study observe decrease smoke topography nicotine cigarette choice varenicline , relative placebo ; decrease day 21 relative day 7 varenicline treatment . We also propose examine extend duration treatment clinical significance decrease smoking behavior , thus increase efficacy varenicline .</brief_summary>
	<brief_title>Measuring Smoking Behaviors While Using Varenicline</brief_title>
	<detailed_description>This study design examine behavioral response cigarette smoker may use varenicline . Behavioral response may help good understand mechanism turn could improve treatment outcomes . The primary hypothesis study observe decrease smoke topography , objective measure smoke behavior puffing , varenicline , relative placebo ; decrease day 21 relative day 7 varenicline treatment . We also examine puff nicotine cigarette choice lab visit baseline , Days 7 21 . We also propose examine extend duration treatment clinical significance decrease smoking behavior , thus potentially increase efficacy varenicline .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>self report minimum 10 daily cigarette self report smoking every day past 5 year ages 2165 self report intention try quit smoke next 6 month self report use nicotinecontaining product nonmenthol cigarette self report history current treatment substance abuse ( nicotine dependence ) self report alcohol use great 25 standard drink per week ; currently pregnant , planned pregnancy lactating ( female : negative urine pregnancy screen ) self report history current diagnosis Axis 1 disorder except past depression self report serious unstable disease within past year self report history epilepsy seizure disorder ; self report history current diagnosis COPD ( chronic obstructive pulmonary disease ) , cardiovascular disease , heart attack , uncontrolled hypertension self report kidney function impairment current recent ( 30 day ) use : smoking cessation medication , antipsychotic , antidepressant , antianxiety , panic medication , stimulant opiatecontaining medication le 5 year daily smoke medical condition concomitant medication could compromise participant safety treatment provide baseline carbon monoxide ( CO ) reading &lt; 10 ppm self report use non filter cigarette inability provide inform consent complete study task determine Principal Investigator and/or Study Physician</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>smoking</keyword>
	<keyword>nicotine</keyword>
	<keyword>varenicline</keyword>
</DOC>